jca

Hot Keywords
Cardiovascular Aging

Top

Two Editorial Board Members Featured in the List of “Highly Cited Researchers 2021” Announced by Clarivate Analytics

Published on: 25 Nov 2021 Viewed: 171

On November 16, 2021, Clarivate Analytics announced the list of “Highly Cited Researchers 2021”. Two Editorial Board Members of The Journal of Cardiovascular Aging (JCA) are on the list. Hereon, all Editors of the JCA are extending warm congratulations to the two scholars on being selected to the list of “Highly Cited Researchers 2021” by Clarivate Analytics.

The introductions of the two members are as follows:

Peter A. Libby
Brigham and Women’s Hospital, Harvard Medical School, USA


Professor Peter A. Libby, Senior Advisory Editor of JCA, cardiovascular medicine specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medical School. His professional memberships include the Association of American Physicians, the American Society for Clinical Investigation, elected honorary memberships in the British Atherosclerosis Society, the Japan Circulation Society, and the Japanese College of Cardiology. He has served as the President of the Association of University Cardiologists. He also has served in many roles as a volunteer for the American Heart Association, including chairman of several research committees and member of the executive committees of the Councils on Arteriosclerosis, Circulation, and Basic Science. He has served two terms as Chairperson of the American College of Cardiology’s Research Allocations Peer Review Committee. He directed the DW Reynolds Cardiovascular Clinical Research Center and two cycles of Leducq Foundation Awards, and has received continuous funding from the National Heart, Lung, and Blood Institute for several decades. He has received numerous awards and recognitions for his research accomplishments include the Gold Medal of the European Society of Cardiology (2011) and the Basic Research Prize of the American Heart Association (2011). His clinical and research interests include vascular biology, atherosclerosis, and preventive cardiology.

Guido Kroemer
Universite de Paris, France


Professor Guido Kroemer, Consulting Editor of JCA, Professor at the Faculty of Medicine of the University of Paris Descartes, Director of the research team “Metabolism, Cancer and Immunity” of the French Medical Research Council (INSERM), Director of the Metabolomics and Cell Biology platforms of the Gustave Roussy Comprehensive Cancer Center, Deputy Director of the Cordeliers Research Center, and Hospital Practitioner at the Hôpital Européen George Pompidou, Paris, France. He is also a Foreign Adjunct Professor at the Karolinska Institute, Stockholm, Sweden. Professor Kroemer is member of the European Molecular Biology Organization (EMBO), German Academy of Sciences (Leopoldina), Austrian Academy of Sciences, Academia Europaea, European Academy of Sciences (EAS), European Academy of Sciences and Arts (EASA), European Academy of Cancer Sciences (EACS), and Institut Universitaire de France (IUF). His contributions have been recognized with numerous awards, including the Gallet & Breton Prize of the French Academy of Medicine (1999), the Carus Medal of the German Academy of Sciences (2007), the Lucien Dautrebande Prize of the Belgian Royal Academy of Medicine (2009), the Léopold Griffuel Prize of the French Association for Cancer Research (2012), the Mitjavile Prize of the French Academy of Medicine (2014), the Galien Prize for Pharmacological Resarch (2015), the Grand Prix Claude Bernard of the City of Paris (2016), the Brupbacher Prize for Cancer Research (2017), the ADPS Longevity Research Award (2018), the Baillet-Latour Health Prize (2018), and the international Lombardia è Ricerca Prize (2019) among others. He focuses on the research of mitochondria and cell death.

Congratulations to our members!


© 2016-2021 OAE Publishing Inc., except certain content provided by third parties